Skip to main content

E Fund Management Co., Ltd.

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1842296 GUANGZHOU, F4

Position in APLS

as of Mar 31, 2026 · filed Apr 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
22,686
+41.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

E Fund Management Co., Ltd. holds $66,079,043 across 109 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 22,686
2025-06-30 16,057
2025-03-31 16,835
2024-12-31 17,162
2024-09-30 13,116
2024-06-30 14,696
2024-03-31 7,032
2023-12-31 7,657
2023-09-30 10,998
2023-06-30 4,963
2023-03-31 6,207
2022-12-31 8,604
2022-09-30 7,050
2022-06-30 10,651
2022-03-31 6,196